Keyphrases
Allergy
100%
Immunological Methods
100%
Total Serum IgE Level
100%
Omalizumab
100%
Xolair
100%
IgE Levels
54%
Free IgE
54%
Total IgE
45%
Human IgE
36%
Asthma Patients
18%
Human Serum
18%
Omalizumab Treatment
18%
Basophils
9%
Allergic Asthma
9%
IgG1
9%
High Affinity
9%
Asthmatic
9%
Solid Phase
9%
Mast Cells
9%
IgE Binding
9%
Humanized
9%
Fc Receptor
9%
Molar Ratio
9%
Monitoring Patients
9%
Working Range
9%
Parallelization
9%
Immunology and Microbiology
Immunoglobulin E
100%
Immunological Method
100%
Omalizumab
100%
Asthma
10%
Serum (Blood)
10%
Allergic Asthma
5%
Immunoglobulin G1
5%
Basophil Granulocyte
5%
Solid
5%
Mast Cell
5%
Fc Receptor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin E
100%
Omalizumab
100%
Asthma
10%
Epileptic Absence
5%
Allergic Asthma
5%
Immunoglobulin G1
5%
Fc Receptor
5%